Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02067039 · ClinicalTrials.gov registry record · NA
Evaluation of Rapid HIV Self-testing Among MSM (eSTAMP)
A NA study, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- NA
- Development phase
- 2,665
- Enrollment target
NCT02067039 is a NA study that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 2,665 participants.
The verdict
NCT02067039, a NA study, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,665 participants
- Enrollment target
Study Summary
This study seeks to determine the public health impact of providing rapid HIV test kits to men who have sex with men (MSM) so they may test themselves at their convenience. The study will determine if men who receive the rapid HIV test kits report HIV testing at least three times per year. This study will be conducted in four consecutive parts. The first three parts are formative in nature to guide the development and implementation of Part 4 of the study. The research study will use two different types of rapid HIV tests. The OraQuick® In-Home HIV Test for oral fluid (FDA approved for home use) and Sure Check® HIV 1/2 Assay, currently FDA-approved for professional use and distributed in the U.S. as Clearview® Complete HIV-1/2 Rapid Test. An Investigational Device Exemption will be obtained from the FDA to allow the contractor to supply the Sure Check® HIV 1/2 Assay to study participants since it is not approved for home use.
Interventions
- DEVICE OraQuick in home & Sure Check HIV tests
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,665 participants |
| Start Date | 2015-03-25 |
| Est. Completion | 2016-10-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02067039
The ClinicalTrials.gov registry entry for NCT02067039 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,665 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which OraQuick in home & Sure Check HIV tests is the first listed.
NCT02067039 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02067039 about?
NCT02067039 is a clinical study titled "Evaluation of Rapid HIV Self-testing Among MSM (eSTAMP)". This study seeks to determine the public health impact of providing rapid HIV test kits to men who have sex with men (MSM) so they may test themselves at their convenience. The study will determine if men who receive the rapid HIV test kits report HIV testing at least three times per year. This stud...
What is the current status of trial NCT02067039?
This trial is currently completed. It is a NA study. The enrollment target is 2,665 participants. The study started on 2015-03-25. Estimated completion is 2016-10-21.
What interventions are being tested in trial NCT02067039?
The interventions under investigation include: OraQuick in home & Sure Check HIV tests (DEVICE).
Who is sponsoring clinical trial NCT02067039?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.